Surgical Outcomes and complications of prophylactic salpingectomy at the time of benign hysterectomy in premenopausal women

Journal of Minimally Invasive Gynecology

Volumn 22, Issue 4, 2015, Pages 653-657

  Minig, Lucas ^a,b   Chuang, Linus ^c   Patrono, María Guadalupe ^b   Cárdenas Rebollo, José Miguel ^b   García Donas, Jesús ^d  

^a Valencian Institute of Pediatric Neurology   (Spain)

^b UNIVERSIDAD SAN PABLO CEU   (Spain)

^c MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^d Hospital HM Madrid Norte Sanchinarro   (Spain)

Author keywords

Benign hysterectomy; Prophylactic salpingectomy; Surgical outcomes

Indexed keywords

ADULT; ARTICLE; BLEEDING; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; HOSPITAL READMISSION; HOSPITALIZATION; HUMAN; HYSTERECTOMY; LENGTH OF STAY; MAJOR CLINICAL STUDY; OPERATION DURATION; PEROPERATIVE COMPLICATION; POSTOPERATIVE COMPLICATION; PREMENOPAUSE; PROPHYLACTIC SURGICAL PROCEDURE; SALPINGECTOMY; TREATMENT OUTCOME; ADVERSE EFFECTS; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PROCEDURES; RETROSPECTIVE STUDY; SPAIN;

FEMALE; HUMANS; HYSTERECTOMY; MIDDLE AGED; OPERATIVE TIME; POSTOPERATIVE COMPLICATIONS; PREMENOPAUSE; RETROSPECTIVE STUDIES; SALPINGECTOMY; SPAIN; TREATMENT OUTCOME;

EID: 84927528121     PISSN: 15534650     EISSN: 15534669     Source Type: Journal    
DOI: 10.1016/j.jmig.2015.02.013     Document Type: Article

References (18)

1. Whiteman M.K., Hillis S.D., Jamieson D.J., et al. Inpatient hysterectomy surveillance in the United States, 2000-2004. Am J Obstet Gynecol 2008, 198:34.e1-34.e7.
2. Center of Disease Control. Hysterectomy Surveillance-United States, 1994-1999. Available at: Accessed December 5,2014. http://www.cdc.gov/mmwr/preview/mmwrhtml/ss5105a1.htm.
3. Ghezzi F., Cromi A., Siesto G., et al. Infectious morbidity after total laparoscopic hysterectomy: does concomitant salpingectomy make a difference?. BJOG 2009, 116:589-593.
4. Morse A.N., Hammer R.A., Walter A.J., et al. Does hysterectomy without adnexectomy in patients with prior tubal interruption increase the risk of subsequent hydrosalpinx?. Am J Obstet Gynecol 2002, 187:1483-1486.
5. Timor-Tritsch I.E., Monteagudo A., Tsymbal T. Three-dimensional ultrasound inversion rendering technique facilitates the diagnosis of hydrosalpinx. J Clin Ultrasound 2010, 38:372-376.
6. Basu D., Ward S.J. Post-hysterectomy fallopian tube prolapse-a diagnostic pitfall. J Obstet Gynaecol 2007, 27:324.
7. Piek J.M., van Diest P.J., Zweemer R.P. Dysplastic changes in prophylactic removed fallopian tubes of women predisposed to developing ovarian cancer. J Pathol 2001, 195:451-456.
8. Sandoval C., Fung-Kee-Fung M., Gilks B., et al. Examining the use of salpingectomy with hysterectomy in Canada. Curr Oncol 2013, 20:173-175.
9. Gill S.E., Mills B.B. Physician opinions regarding elective bilateral salpingectomy with hysterectomy and for sterilization. J Minim Invasive Gynecol 2013, 20:517-521.
10. Parker W.H., Broder M.S., Liu Z., et al. Ovarian conservation at the time of hysterectomy for benign disease. Obstet Gynecol 2005, 106:219-226.
11. Chan C.C., Ng E.H., Li C.F., et al. Impaired ovarian blood flow and reduced antral follicle count following laparoscopic salpingectomy for ectopic pregnancy. Hum Reprod 2003, 18:2175-2180.
12. Sezik M., Ozkaya O., Demir F., et al. Total salpingectomy during abdominal hysterectomy: effects on ovarian reserve and ovarian stromal blood flow. J Obstet Gynaecol Res 2007, 33:863-869.
13. Morelli M., Venturella R., Mocciaro R., et al. Prophylactic salpingectomy in premenopausal low-risk women for ovarian cancer: primum non nocere. Gynecol Oncol 2013, 129:448-451.
14. The role of tubal surgery in the era of assisted reproductive technology. Fertil Steril 2012, 97:539-545. American Society for Reproductive Medicine.
15. Guldberg R., Wehberg S., Skovlund C.W., et al. Salpingectomy as standard at hysterectomy? A Danish cohort study, 1977-2010. BMJ Open 2013, 20:3.
16. Kurman R.J., Shih I.M. Molecular pathogenesis and extraovarian origin of epithelial ovarian cancer-shifting the paradigm. Hum Pathol 2011, 42:918-931.
17. Dietl J., Wischhusen J., Häusler S.F. The post-reproductive Fallopian tube: better removed?. Hum Reprod 2011, 26:2918-2924.
18. Piek J.M., Verheijen R.H., Kenemans P., et al. BRCA1/2-related ovarian cancers are of tubal origin: a hypothesis. Gynecol Oncol 2003, 90:491.